IMS MAXIMS Unveils a New Package of IT Deployment Choices

IMS MAXIMSIMS MAXIMS is unveiling a new range of deployment models giving customers four ways to access its proven clinical patient administration system (PAS). The four choices are designed to ensure that healthcare providers of every size, and with very different resources, can all benefit from the best clinical applications and electronic patient record systems.

Shane Tickell, IMS MAXIMS CEO, said: "We spend a lot of time talking to customers and are always looking for new ways to respond to their needs. As a result we fully understand the different capabilities and aspirations across NHS trusts and other healthcare providers. Right now they need a flexible range of options to obtain access to the best possible clinical and administrative IT systems. Our four choices cater for the different sizes, resources and skills available within the ever-growing variety of healthcare providers that exists in the UK and Ireland.

"Customers now have complete freedom to customise their own MAXIMS system in-house or deploy our specialists to configure according to their specifications. Smaller organisations, like independent clinics, with limited IT skills and budgets, can even rent an off-the-shelf software-as-a-service version of MAXIMS. This gives them affordable access to a Choose and Book compliant clinical PAS of the highest standards - vital for winning NHS contracts."

The four options

  • MAXIMS Toolkit: All the essentials for creating and customising your own MAXIMS clinical PAS, in your own time, using your own resources and capabilities.
  • MAXIMS Assist: The core MAXIMS systems pre-packaged with essential assessments capability, allowing your own tailoring and enhancements.
  • MAXIMS Bespoke: Complete turnkey delivery customised to suit your specifications and requirements and fully-integrated with your existing systems.
  • MAXIMS SaaS: Off-the-shelf Choose and Book compliant, software-as-a-service alternative. Sized to the exact number of users it provides a low capital outlay way to benefit from the best in clinical PAS technology.

MAXIMS is at the heart of the clinical and administrative life of everything from large UK and Irish hospitals, to growing specialist independent clinics. It gives patient data to clinicians in exactly the format they need, and allows it to be shared with colleagues and updated in real-time. MAXIMS suits any clinical specialism and is excellent for order communications and reporting. Medical and administrative records can be kept fully up to date, with the minimum of effort. MAXIMS is web-based so there is no need to install software on computers or invest in expensive extra hardware.

IMS MAXIMS is the company behind the widely-used MAXIMS clinical PAS. It is a specialist in developing clinical and administrative software solutions and currently supports more than 100 organisations and 10,000 users of IMS MAXIMS products.

About the MAXIMS clinical PAS
MAXIMS gives clinicians the applications they need to provide the best possible patient care, and allows provider organisations to manage their patient administration with ease and efficiency. Rival products often tend to be administrative systems with clinical software added on. MAXIMS is equally focused on the needs of clinicians and provider organisations - which we believe is the way to guarantee the best patient outcomes with optimum efficiency.

Most Popular Now

Welcome Evo, Generative AI for the Genom…

Brian Hie runs the Laboratory of Evolutionary Design at Stanford, where he works at the crossroads of artificial intelligence and biology. Not long ago, Hie pondered a provocative question: If...

We could Soon Use AI to Detect Brain Tum…

A new paper in Biology Methods and Protocols, published by Oxford University Press, shows that scientists can train artificial intelligence (AI) models to distinguish brain tumors from healthy tissue. AI...

Telehealth Significantly Boosts Treatmen…

New research reveals a dramatic improvement in diagnosing and curing people living with hepatitis C in rural communities using both telemedicine and support from peers with lived experience in drug...

Research Study Shows the Cost-Effectiven…

Earlier research showed that primary care clinicians using AI-ECG tools identified more unknown cases of a weak heart pump, also called low ejection fraction, than without AI. New study findings...

Remote Telemedicine Tool Found Highly Ac…

Collecting images of suspicious-looking skin growths and sending them off-site for specialists to analyze is as accurate in identifying skin cancers as having a dermatologist examine them in person, a...

New Guidance for Ensuring AI Safety in C…

As artificial intelligence (AI) becomes more prevalent in health care, organizations and clinicians must take steps to ensure its safe implementation and use in real-world clinical settings, according to an...

Philips Aims to Advance Cardiac MRI Tech…

Royal Philips (NYSE: PHG, AEX: PHIA) and Mayo Clinic announced a research collaboration aimed at advancing MRI for cardiac applications. Through this investigation, Philips and Mayo Clinic will look to...

New Study Reveals Why Organisations are …

The slow adoption of blockchain technology is partly driven by overhyped promises that often obscure the complex technological, organisational, and environmental challenges, according to research from the University of Surrey...

Deep Learning Model Accurately Diagnoses…

Using just one inhalation lung CT scan, a deep learning model can accurately diagnose and stage chronic obstructive pulmonary disease (COPD), according to a study published today in Radiology: Cardiothoracic...

Shape-Changing Device Helps Visually Imp…

Researchers from Imperial College London, working with the company MakeSense Technology and the charity Bravo Victor, have developed a shape-changing device called Shape that helps people with visual impairment navigate...

Bayer Acquires HiDoc Technologies and Ca…

Bayer is today announcing that it plans to acquire HiDoc Technologies GmbH in the first quarter of 2025 and to start commercialization of the digital health application, Cara Care®. Cara...

Almost All Leading AI Chatbots Show Sign…

Almost all leading large language models or "chatbots" show signs of mild cognitive impairment in tests widely used to spot early signs of dementia, finds a study in the Christmas...